IPH2201

Monalizumab

Monoclonal antibody
Type	?
Legal status
Legal status	Investigational
Identifiers
CAS Number	1228763-95-8
ChemSpider	none

Monalizumab (formerly IPH2201) is an investigational drug being studied for rheumatoid arthritis, gynecologic malignancies, and other cancers.

Monalizumab is a monoclonal antibody targeted at NKG2A. It is a checkpoint inhibitor.

...
Wikipedia